Evidence map›Paper›PMID 24386342›Full record

ArticlePloS one2013

Cefotaxime resistant Escherichia coli collected from a healthy volunteer; characterisation and the effect of plasmid loss.

Miranda Kirchner, Manal Abuoun, Muriel Mafura, Mary Bagnall, Theresa Hunt, Christopher Thomas, Jan Weile, Muna F Anjum

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Miranda KirchnerDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Addlestone, Surrey, United Kingdom.
Manal AbuounDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Addlestone, Surrey, United Kingdom.
Muriel MafuraDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Addlestone, Surrey, United Kingdom.
Mary BagnallDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Addlestone, Surrey, United Kingdom.
Theresa HuntDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Addlestone, Surrey, United Kingdom.
Christopher ThomasSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Jan WeileInstitute for Laboratory and Transfusion Medicine at the Heart and Diabetes Centre, University Hospital of the Ruhr University, Bochum, Germany.
Muna F AnjumDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Addlestone, Surrey, United Kingdom.
Animal and Plant Health Agency · GBUniversity Hospitals of the Ruhr-University of Bochum · DEUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study 6 CTX-M positive E. coli isolates collected during a clinical study examining the effect of antibiotic use in a human trial were analysed. The aim of the study was to analyse these isolates and assess the effect of full or partial loss of plasmid genes on bacterial fitness and pathogenicity. A DNA array was utilised to assess resistance and virulence gene carriage. Plasmids were characterised by PCR-based replicon typing and addiction system multiplex PCR. A phenotypic array and insect virulence model were utilised to assess the effect of plasmid-loss in E. coli of a large multi-resistance plasmid. All six E. coli carrying bla CTX-M-14 were detected from a single participant and were identical by pulse field gel electrophoresis and MLST. Plasmid profiling and arrays indicated absence of a large multi-drug resistance (MDR) F-replicon plasmid carrying blaTEM, aadA4, strA, strB, dfrA17/19, sul1, and tetB from one isolate. Although this isolate partially retained the plasmid it showed altered fitness characteristics e.g. inability to respire in presence of antiseptics, similar to a plasmid-cured strain. However, unlike the plasmid-cured or plasmid harbouring strains, the survival rate for Galleria mellonella infected by the former strain was approximately 5-times lower, indicating other possible changes accompanying partial plasmid loss. In conclusion, our results demonstrated that an apparently healthy individual can harbour bla CTX-M-14 E. coli strains. In one such strain, isolated from the same individual, partial absence of a large MDR plasmid resulted in altered fitness and virulence characteristics, which may have implications in the ability of this strain to infect and any subsequent treatment.

Indexed as

Healthy VolunteersAnti-Bacterial Agentsbeta-LactamasesCefotaximeDrug Resistance, BacterialEscherichia coliGenotypeHumansPhenotypePlasmidsAnti-Bacterial Agentsbeta-lactamase CTX-2beta-LactamasesCefotaxime

Identifiers

PMID24386342
PMCPMC3873979
OpenAlexW1982908350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.